Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
William (Bill) Hyun
AddedMar 31, 2024
UpdatedJun 28, 2026
William (Bill) Hyun

William (Bill) Hyun

Founder, BioInfleXion Point Partners

CrunchbaseLinkedIn

William (Bill) Hyun's Career

BioInfleXion Point Partners
BioInfleXion Point Partners

Belmont, CA, US

Founder
Scribe Biosciences
Scribe Biosciences

San Francisco, CA, US

Board Member· Board
Vitra Bioscience
Vitra Bioscience

Mountain, WI, US

Founder
Fluent BioSciences
Fluent BioSciences

Watertown, MA, US

Board Member· Board
Slingshot Biosciences
Slingshot Biosciences

Emeryville, CA, US

Board Member· Board
Akadeum Life Sciences
Akadeum Life Sciences

Ann Arbor, MI, US

Board Member· Board
Mission Bio
Mission Bio

South San Francisco, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

William (Bill) Hyun's Career

BioInfleXion Point Partners
BioInfleXion Point Partners
62013Belmont, CA, US
Founder
Scribe Biosciences
Scribe Biosciences
Seed$3.1M72017San Francisco, CA, US
Board Member· Board

Leadership at Scribe Biosciences

Russell ColeRussell ColeCo-Founder
Maithreyan SrinivasanMaithreyan SrinivasanCo-Founder
Vitra Bioscience
Vitra Bioscience
Series A$5.5M301999Mountain, WI, US
Founder

Similar to Vitra Bioscience

CelldomCelldomDurham, NC, USSingle-Cell Analysisest. 2016CelldomDurham, NC, US · est. 2016

Celldom advances research and drug development with high-throughput, next-gen single-cell analysis technology.

Seed · $1.9M5
Partillion BiosciencePartillion BioscienceLos Angeles, CA, USLife Scienceest. 2020Partillion BioscienceLos Angeles, CA, US · est. 2020

Partillion Bioscience: A life science company innovating single-cell analysis for probing biological functions.

Seed · $6.1M5
Thrive BioscienceThrive BioscienceBeverly, MA, USInstruments, Softwareest. 2014Thrive BioscienceBeverly, MA, US · est. 2014

Thrive Bioscience: Pioneering in automated live cell imaging and analytics for drug discovery and research.

Series B · $25.7M35
Fluent BioSciences
Fluent BioSciences
Series B$22.9M192018Watertown, MA, US
Board Member· Board

Leadership at Fluent BioSciences

Mike DybbsMike DybbsBoard Member
Wouter MeulemanWouter MeulemanBoard Member
Tim HarknessTim HarknessBoard Member
Gary ZweigerGary ZweigerCo-Founder
Sepehr KianiSepehr KianiCo-Founder
Adam AbateAdam AbateBoard Member

Similar to Fluent BioSciences

Parse BiosciencesParse BiosciencesSeattle, WA, USData Analysis, Sequencingest. 2018Parse BiosciencesSeattle, WA, US · est. 2018

Seattle-based Parse Biosciences offers scalable single-cell sequencing platforms to accelerate scientific research.

Series C · $100M119
FluidigmFluidigmSouth San Francisco, CA, USBiotechnologyest. 1999FluidigmSouth San Francisco, CA, US · est. 1999

Standard BioTools Inc., based in South San Francisco, accelerates life sciences research with essential, standardized technologies.

Public615
FlexomicsFlexomicsBoston, MA, USScreening Platformest. 2019FlexomicsBoston, MA, US · est. 2019

Flexomics: A high-throughput screening platform bridging genomic and functional analysis.

Seed · $2M4
10x Genomics10x GenomicsPleasanton, CA, USGene Sequencingest. 201210x GenomicsPleasanton, CA, US · est. 2012

10x Genomics: A leading American biotech firm, innovating in gene sequencing since 2012.

Public · $242.6M448
Slingshot Biosciences
Slingshot Biosciences
Series A$34M732012Emeryville, CA, US
Board Member· Board

Leadership at Slingshot Biosciences

Corey RitterCorey RitterBoard Member
Jeff KimJeff KimFounder
Adam WieschhausAdam WieschhausBoard Member

Similar to Slingshot Biosciences

SynlifeSynlifeCambridge, MA, USMedical Researchest. 2017SynlifeCambridge, MA, US · est. 2017

Synlife: Innovating therapeutic and diagnostic solutions through engineered synthetic cells for medical research.

Seed · $700k2
Think BioscienceThink BioscienceBoulder, CO, USMedicinesest. 2019Think BioscienceBoulder, CO, US · est. 2019

Think Bioscience innovates synthetic biology, designing superior medicines using living systems.

Seed · $17.3M26
CellanomeCellanomePalo Alto, CA, USSynthetic Biologyest. 2020CellanomePalo Alto, CA, US · est. 2020

Cellanome, a synthetic biology firm, leverages a multi-omics platform for innovative molecular solutions.

Series A · $63.7M33
SpheringenicsSpheringenicsAtlanta, GA, USCell Therapiesest. 2007SpheringenicsAtlanta, GA, US · est. 2007

SpherIngenics: Leading biotech firm specializing in innovative cell-based medicinal therapies.

Pre-Seed · $730k4
Akadeum Life Sciences
Akadeum Life Sciences
Series B$21.5M352014Ann Arbor, MI, US
Board Member· Board

Leadership at Akadeum Life Sciences

Brandon McNaughtonBrandon McNaughtonFounder & CEO
Dan KidleDan KidleBoard Member
Mission Bio
Mission Bio
Series D$150.9M1222014South San Francisco, CA, US
Board Member· Board

Leadership at Mission Bio

Brian KimBrian KimBoard Member
Adam AbateAdam AbateCo-Founder
Charlie SilverCharlie SilverCo-Founder
Allison BallmerAllison BallmerBoard Member
Dennis EastburnDennis EastburnCo-Founder
Adam SciambiAdam SciambiCo-Founder

William (Bill) Hyun's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to William (Bill) Hyun

Daniel WagnerDaniel WagnerBoard Member · FMP ProductsWinnie H WanWinnie H WanBoard Member · Life Science AngelsAndrew ChungAndrew ChungFounder · 1955 CapitalMichael YangMichael YangBoard Member · Kiwi CrateDouglas RothDouglas RothBoard Member · NIXXY